Theranostic implications of nanotechnology in multiple sclerosis: A future perspective

Autoimmune Diseases

Volumn 1, Issue 1, 2012, Pages

  Singh, Ajay Vikram ^a,b   Khare, Manish ^c   Gade, W N ^a   Zamboni, Paolo ^d  

^a UNIVERSITY OF PUNE   (India)

^b RENSSELAER POLYTECHNIC INSTITUTE   (United States)

^c Maharashtra Institute of Pharmacy   (India)

^d UNIVERSITY OF FERRARA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; DRUG VEHICLE; GOLD NANOPARTICLE; MULTI WALLED NANOTUBE; NANOBODY; NANOPARTICLE; SILVER NANOPARTICLE; SINGLE WALLED NANOTUBE;

ARTIFICIAL CELL; ATOMIC FORCE MICROSCOPY; BLOOD BRAIN BARRIER; CELL INFILTRATION; CENTRAL NERVOUS SYSTEM DISEASE; DIAGNOSTIC ACCURACY; DRUG DELIVERY SYSTEM; DRUG TRANSPORT; HUMAN; IN VIVO STUDY; INFLAMMATION; MICELLE; MULTIPLE SCLEROSIS; NANOTECHNOLOGY; NERVOUS SYSTEM INFLAMMATION; NEUROPATHOLOGY; NEUROPROTECTION; NEUROSURGERY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOGENESIS; PRIORITY JOURNAL; PROGNOSIS; RADIODIAGNOSIS; RETICULOENDOTHELIAL SYSTEM; REVIEW;

EID: 84872826973     PISSN: None     EISSN: 20900430     Source Type: Journal    
DOI: 10.1155/2012/160830     Document Type: Review

References (111)

1. Comston A., Coles A., Multiple sclerosis. The Lancet 2002 359 9313 1221 1231 (Pubitemid 34304266)
2. Bobholz J. A., Gremley S., Multiple sclerosis and other demyelinating disorders. The Little Black Book of Neuropsychology 2011 647 661
3. Smith K. J., McDonald W. I., The pathophysiology of multiple sclerosis: the mechanisms underlying the production of symptoms and the natural history of the disease. Philosophical Transactions of the Royal Society B 1999 354 1390 1649 1673 (Pubitemid 29534432)
4. Debouverie M., Pittion-Vouyovitch S., Louis S., Guillemin F., Natural history of multiple sclerosis in a population-based cohort. European Journal of Neurology 2008 15 9 916 921 2-s2.0-49549118231 10.1111/j.1468-1331.2008.02241.x
5. Jones C. A., Pohar S. L., Warren S., Turpin K. V., Warren K. G., The burden of multiple sclerosis: a community health survey. Health and Quality of Life Outcomes 2008 6, article 1 2-s2.0-41649111052 10.1186/1477-7525-6-1 (Pubitemid 351359625)
6. Manfredini F., Malagoni A. M., Mandini S., Felisatti M., Mascoli F., Basaglia N., Manfredini R., Mikhailidis D. P., Zamboni P., Near-infrared spectroscopy assessment following exercise training in patients with intermittent claudication and in untrained healthy participants. Vascular and Endovascular Surgery 2012 46 4 315 324 10.1177/1538574412443318
7. Hemmer B., Archelos J. J., Hartung H. P., New concepts in the immunopathogenesis of multiple sclerosis. Nature Reviews Neuroscience 2002 3 4 291 301 2-s2.0-0036546066 10.1038/nrn784 (Pubitemid 135706608)
8. Carrieri P. B., Petracca M., Montella S., Delfino M., Sepe C., Gattoni A., Multiple sclerosis and systemic sclerosis: efficacy of interferon beta on skin lesions. Annals of the Rheumatic Diseases 2008 67 8 1192 1193 2-s2.0-47949117750 10.1136/ard.2008.087973
9. Ascherio A., Munger K. L., Environmental risk factors for multiple sclerosis. Part I: the role of infection. Annals of Neurology 2007 61 4 288 299 2-s2.0-34247590137 10.1002/ana.21117 (Pubitemid 46676728)
10. Lublin F. D., Reingold S. C., Defining the clinical course of multiple sclerosis: results of an international survey. Neurology 1996 46 4 907 911 2-s2.0-0029913882 (Pubitemid 26134623)
11. Kurtzke J. F., Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 1983 33 11 1444 1452 2-s2.0-0021035886 (Pubitemid 14237132)
12. Silva G. A., Neuroscience nanotechnology: progress, opportunities and challenges. Nature Reviews Neuroscience 2006 7 1 65 74 2-s2.0-29244472857 10.1038/nrn1827 (Pubitemid 41828932)
13. Orive G., Anitua E., Pedraz J. L., Emerich D. F., Biomaterials for promoting brain protection, repair and regeneration. Nature Reviews Neuroscience 2009 10 9 682 692 2-s2.0-69249217640 10.1038/nrn2685
14. Lin L. N., Liu Q., Song L., Liu F. F., Sha J. X., Recent advances in nanotechnology based drug delivery to the brain. Cytotechnology 2010 62 5 377 380 2-s2.0-78651478325 10.1007/s10616-010-9295-8
15. Kanwar J. R., Sun X., Punj V., Sriramoju B., Mohan R. R., Zhou S.-F., Chauhan A., Kanwar R. K., Nanoparticles in the treatment and diagnosis of neurological disorders: untamed dragon with fire power to heal. Nanomedicine 2012 8 4 399 414 10.1016/j.nano.2011.08.006
16. Neuwelt E. A., Bauer B., Fahlke C., Fricker G., Iadecola C., Janigro D., Leybaert L., Molnár Z., O'Donnell M. E., Povlishock J. T., Saunders N. R., Sharp F., Stanimirovic D., Watts R. J., Drewes L. R., Engaging neuroscience to advance translational research in brain barrier biology. Nature Reviews Neuroscience 2011 12 3 169 182 10.1038/nrn2995
17. Srikanth M., Kessler J. A., Nanotechnology-novel therapeutics for CNS disorders. Nature Reviews Neurology 2012 8 6 307 318 10.1038/nrneurol.2012.76
18. Fazil M., Shadab B. S., Sahni J. K., Ali J., Nanotherapeutics for Alzheimer's disease (AD): past, present and future. Journal of Drug Targeting 2012 20 2 97 113
19. Saunders N. R., Ek C. J., Habgood M. D., Dziegielewska K. M., Barriers in the brain: a renaissance? Trends in Neurosciences 2008 31 6 279 286 2-s2.0-44549085953 10.1016/j.tins.2008.03.003
20. Pardridge W. M., Molecular biology of the blood-brain barrier. Molecular Biotechnology 2005 30 1 57 69 2-s2.0-26244456551 (Pubitemid 41411169)
21. Zeis T., Probst A., Steck A. J., Molecular changes in white matter adjacent to an active demyelinating lesion in early multiple sclerosis. Brain Pathology 2009 19 3 459 466
22. Zamboni P., The Big Idea: iron-dependent inflammation in venous disease and proposed parallels in multiple sclerosis. Journal of the Royal Society of Medicine 2006 99 11 589 593 2-s2.0-33845317597 (Pubitemid 44876813)
23. Zamboni P., Galeotti R., Menegatti E., Malagoni A. M., Tacconi G., Dall'ara S., Bartolomei I., Salvi F., Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 2009 80 4 392 399 2-s2.0-64749109556 10.1136/jnnp.2008.157164
24. Laupacis A., Lillie E., Dueck A., Straus S., Perrier L., Burton J. M., Aviv R., Spears J., Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a meta-analysis. CMAJ 2011 183 16 E1203 E1212 10.1503/cmaj.111074
25. Zivadinov R., Ramanathan M., Dolic K., Marr K., Karmon Y., Siddiqui A. H., Benedict R. H. B., Weinstock-Guttman B., Chronic cerebrospinal venous insufficiency in multiple sclerosis: diagnostic, pathogenetic, clinical and treatment perspectives. Expert Review of Neurotherapeutics 2011 11 9 1277 1294 10.1586/ern.11.117
26. Zamboni P., Menegatti E., Weinstock-Guttman B., Dwyer M. G., Schirda C. V., Malagoni A. M., Hojnacki D., Kennedy C., Carl E., Bergsland N., Magnano C., Bartolomei I., Salvi F., Zivadinov R., Hypoperfusion of brain parenchyma is associated with the severity of chronic cerebrospinal venous insufficiency in patients with multiple sclerosis: a cross-sectional preliminary report. BMC Medicine 2011 9, article 22 2-s2.0-79952633344 10.1186/1741-7015-9-22
27. D'haeseleer M., Cambron M., Vanopdenbosch L., De Keyser J., Vascular aspects of multiple sclerosis. The Lancet Neurology 2011 10 7 657 666 2-s2.0-79958806439 10.1016/S1474-4422(11)70105-3
28. Henderson A. P. D., Barnett M. H., Parratt J. D. E., Prineas J. W., Multiple sclerosis: distribution of inflammatory cells in newly forming lesions. Annals of Neurology 2009 66 6 739 753 2-s2.0-73549089256 10.1002/ana.21800
29. LeVine S. M., Chakrabarty A., The role of iron in the pathogenesis of experimental allergic encephalomyelitis and multiple sclerosis. Annals of the New York Academy of Sciences 2004 1012 252 266 2-s2.0-1842556542 10.1196/annals.1306.021 (Pubitemid 38453530)
30. Singh A. V., Zamboni P., Anomalous venous blood flow and iron deposition in multiple sclerosis. Journal of Cerebral Blood Flow and Metabolism 2009 29 12 1867 1878 2-s2.0-72049108661 10.1038/jcbfm.2009.180
31. D'Aversa T. G., Mylin basic protein induces inflamattory mediatirs from primary human endothelial cells and blood brain barrier disruption: implications of the multiple sclerosis. Neuropathology and Applied Neurobiology. In press
32. Wankhede M., Bouras A., Kaluzova M., Hadjipanayis C. G., Magnetic nanoparticles: an emerging technology for malignant brain tumor imaging and therapy. Expert Review of Clinical Pharmacology 2012 5 2 173 186 10.1586/ecp.12.1
33. De Rosa G., Salzano G., Caraglia M., Abbruzzese A., Nanotechnologies: a strategy to overcome blood-brain barrier. Current Drug Metabolism 2012 13 1 61 69
34. Silva G. A., Nanotechnology approaches to crossing the blood-brain barrier and drug delivery to the CNS. BMC Neuroscience 2008 9 supplement 3, article S4 2-s2.0-57649136406 10.1186/1471-2202-9-S2-S4
35. Siwak D. R., Tari A. M., Lopez-Berestein G., The potential of drug-carrying immunoliposomes as anticancer agents. Clinical Cancer Research 2002 8 4 955 956 2-s2.0-0036554870 (Pubitemid 35177341)
36. Patel T., Zhou J., Piepmeier J. M., Saltzman W. M., Polymeric nanoparticles for drug delivery to the central nervous system. Advanced Drug Delivery Reviews 2012 64 7 701 705 10.1016/j.addr.2011.12.006
37. Rivest V., Phivilay A., Julien C., Bélanger S., Tremblay C., Émond V., Calon F., Novel liposomal formulation for targeted gene delivery. Pharmaceutical Research 2007 24 5 981 990 2-s2.0-34247557118 10.1007/s11095-006-9224-x (Pubitemid 46675400)
38. Sun N.-F., Meng Q.-Y., Tian A.-L., Hu S.-Y., Wang R.-H., Liu Z.-X., Xu L., Nanoliposome-mediated FL/TRAIL double-gene therapy for colon cancer: in vitro and in vivo evaluation. Cancer Letters 2012 315 1 69 77 10.1016/j.canlet.2011.10.010
39. Singh A. V., Lenardi C., Gailite L., Gianfelice A., Milani P., A simple lift-off-based patterning method for micro- and nanostructuring of functional substrates for cell culture. Journal of Micromechanics and Microengineering 2009 19 11 2-s2.0-70350666528 10.1088/0960-1317/19/11/115028 115028
40. Singh A. V., Gailite L., Vyas V., Lenardi C., Forti S., Matteoli M., Milani P., Rapid prototyping of nano- and micro-patterned substrates for the control of cell neuritogenesis by topographic and chemical cues. Materials Science and Engineering C 2011 31 5 892 899 2-s2.0-79956127235 10.1016/j.msec.2011.02.006
41. Swi Chang T. M., Therapeutic applications of polymeric artificial cells. Nature Reviews Drug Discovery 2005 4 3 221 235 10.1038/nrd1659 (Pubitemid 40372556)
42. Orive G., Hernández R. M., Gascón A. R., Calafiore R., Chang T. M. S., De Vos P., Hortelano G., Hunkeler D., Lacík I., Shapiro A. M. J., Pedraz J. L., Cell encapsulation: promise and progress. Nature Medicine 2003 9 1 104 107 10.1038/nm0103-104 (Pubitemid 36098269)
43. Knippenberg S., Thau N., Dengler R., Brinker T., Petri S., Intracerebroventricular injection of encapsulated human mesenchymal cells producing glucagon-like peptide 1 prolongs survival in a mouse model of als. PLoS ONE 2012 7 6 e36857 10.1371/journal.pone.0036857
44. Fernandes R., Gracias D. H., Self-folding polymeric containers for encapsulation and delivery of drugs. Advanced Drug Delivery Reviews 2012 64 14 1579 1589 10.1016/j.addr.2012.02.012
45. Ausländer S., Wieland M., Fussenegger M., Smart medication through combination of synthetic biology and cell microencapsulation. Metabolic Engineering 2012 14 3 252 260 10.1016/j.ymben.2011.06.003
46. Aebischer P., Schluep M., Déglon N., Joseph J.-M., Hirt L., Heyd B., Goddard M., Zurn A. D., Kato A. C., Regli F., Baetge E. E., Intrathecal delivery of CNTF using encapsulated genetically modified xenogeneic cells in amyotrophic lateral sclerosis patients. Nature Medicine 1996 2 6 696 699 10.1038/nm0696-696 (Pubitemid 26191960)
47. Emerich D. F., Orive G., Borlongan C., Tales of biomaterials, molecules, and cells for repairing and treating brain dysfunction. Current Stem Cell Research and Therapy 2011 6 3 171 189 10.2174/157488811796575350
48. Malarkey E. B., Parpura V., Czernicki Z., Carbon nanotubes in neuroscience. Brain Edema XIV 2010 Vienna, Austria Springer 337 341
49. Modi G., Pillay V., Choonara Y. E., Advances in the treatment of neurodegenerative disorders employing nanotechnology. Annals of the New York Academy of Sciences 2010 1184 154 172 2-s2.0-77949884839 10.1111/j.1749-6632. 2009.05108.x
50. Lee W., Parpura V., Chapter 6-carbon nanotubes as substrates/scaffolds for neural cell growth. Progress in Brain Research 2009 180 110 125 2-s2.0-77953418123
51. Cellot G., Cilia E., Cipollone S., Rancic V., Sucapane A., Giordani S., Gambazzi L., Markram H., Grandolfo M., Scaini D., Gelain F., Casalis L., Prato M., Giugliano M., Ballerini L., Carbon nanotubes might improve neuronal performance by favouring electrical shortcuts. Nature Nanotechnology 2009 4 2 126 133 2-s2.0-59849104708 10.1038/nnano.2008.374
52. Huang Y.-J., Wu H.-C., Tai N.-H., Wang T.-W., Carbon nanotube rope with electrical stimulation promotes the differentiation and maturity of neural stem cells. Small 2012 8 18 2869 2877 10.1002/smll.201200715
53. Nunes A., Al-Jamal K. T., Kostarelos K., Therapeutics, imaging and toxicity of nanomaterials in the central nervous system. Journal of Controlled Release 2012 161 2 290 306 10.1016/j.jconrel.2012.03.026
54. Qiu L., Zheng C., Jin Y., Zhu K., Polymeric micelles as nanocarriers for drug delivery. Expert Opinion on Therapeutic Patents 2007 17 7 819 830 2-s2.0-34547872749 10.1517/13543776.17.7.819 (Pubitemid 47249146)
55. Tang R., Ji W., Wang C., PH-responsive micelles based on amphiphilic block copolymers bearing ortho ester pendants as potential drug carriers. Macromolecular Chemistry and Physics 2011 212 11 1185 1192 2-s2.0-79957669459 10.1002/macp.201100007
56. Zhu Z., Senses E., Akcora P., Sukhishvili S. A., Programmable light-controlled shape changes in layered polymer nanocomposites. ACS Nano 2012 6 4 3152 3162 10.1021/nn204938j
57. Ouyang J., Chu C. W., Szmanda C. R., Ma L., Yang Y., Programmable polymer thin film and non-volatile memory device. Nature Materials 2004 3 12 918 922 2-s2.0-10044271110 10.1038/nmat1269
58. Petros R. A., Desimone J. M., Strategies in the design of nanoparticles for therapeutic applications. Nature Reviews Drug Discovery 2010 9 8 615 627 10.1038/nrd2591
59. Rosen H., Abribat T., The rise and rise of drug delivery. Nature Reviews Drug Discovery 2005 4 5 381 385 2-s2.0-18944403564 10.1038/nrd1721 (Pubitemid 40704121)
60. Xiong X.-B., Falamarzian A., Garg S. M., Lavasanifar A., Engineering of amphiphilic block copolymers for polymeric micellar drug and gene delivery. Journal of Controlled Release 2011 155 2 248 261 10.1016/j.jconrel.2011.04.028
61. Ruoslahti E., Bhatia S. N., Sailor M. J., Targeting of drugs and nanoparticles to tumors. Journal of Cell Biology 2010 188 6 759 768 2-s2.0-77949762340 10.1083/jcb.200910104
62. Singh A. V., Subhashree L., Milani P., Gemmati D., Zamboni P., Interplay of iron metallobiology, metalloproteinases, and FXIII, and role of their gene variants in venous leg ulcer. International Journal of Lower Extremity Wounds 2010 9 4 166 179 2-s2.0-78650384117 10.1177/1534734610384653
63. Seabrook T. J., Littlewood-Evans A., Brinkmann V., Pöllinger B., Schnell C., Hiestand P. C., Angiogenesis is present in experimental autoimmune encephalomyelitis and pro-angiogenic factors are increased in multiple sclerosis lesions. Journal of Neuroinflammation 2010 7, article 95 2-s2.0-78650348569 10.1186/1742-2094-7-95
64. Holley J. E., Newcombe J., Whatmore J. L., Gutowski N. J., Increased blood vessel density and endothelial cell proliferation in multiple sclerosis cerebral white matter. Neuroscience Letters 2010 470 1 65 70 2-s2.0-74149084257 10.1016/j.neulet.2009.12.059
65. Van Horssen J., Dijkstra C. D., De Vries H. E., The extracellular matrix in multiple sclerosis pathology. Journal of Neurochemistry 2007 103 4 1293 1301 2-s2.0-35448936315 10.1111/j.1471-4159.2007.04897.x (Pubitemid 47631831)
66. Neri D., Bicknell R., Tumour vascular targeting. Nature Reviews Cancer 2005 5 6 436 446 2-s2.0-20344367537 10.1038/nrc1627 (Pubitemid 40791486)
67. Von Maltzahn G., Park J.-H., Lin K. Y., Singh N., Schwöppe C., Mesters R., Berdel W. E., Ruoslahti E., Sailor M. J., Bhatia S. N., Nanoparticles that communicate in vivo to amplify tumour targeting. Nature Materials 2011 10 7 545 552 10.1038/nmat3049
68. Uttara B., Singh A. V., Zamboni P., Mahajan R. T., Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options. Current Neuropharmacology 2009 7 1 65 74 2-s2.0-65949121134 10.2174/157015909787602823
69. Franklin R. J. M., Ffrench-Constant C., Remyelination in the CNS: from biology to therapy. Nature Reviews Neuroscience 2008 9 11 839 855 10.1038/nrn2480
70. Schubert D., Dargusch R., Raitano J., Chan S. W., Cerium and yttrium oxide nanoparticles are neuroprotective. Biochemical and Biophysical Research Communications 2006 342 1 86 91 2-s2.0-32644468773 10.1016/j.bbrc.2006.01.129 (Pubitemid 43247363)
71. Zhang L., Alizadeh D., Badie B., Carbon nanotube uptake and toxicity in the brain. Methods in Molecular Biology 2010 625 55 65 2-s2.0-77956201191 10.1007/978-1-60761-579-8-6
72. Dugan L. L., Turetsky D. M., Du C., Lobner D., Wheeler M., Almli C. R., Shen C. K.-F., Luh T.-Y., Choi D. W., Lin T.-S., Carboxyfullerenes as neuroprotective agents. Proceedings of the National Academy of Sciences of the United States of America 1997 94 17 9434 9439 10.1073/pnas.94.17.9434 (Pubitemid 27357847)
73. Ali S. S., Hardt J. I., Dugan L. L., SOD Activity of carboxyfullerenes predicts their neuroprotective efficacy: a structure-activity study. Nanomedicine 2008 4 4 283 294 2-s2.0-55949103187 10.1016/j.nano.2008.05.003
74. Dugan L. L., Lovett E. G., Quick K. L., Lotharius J., Lin T. T., O'Malley K. L., Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism and Related Disorders 2001 7 3 243 246 2-s2.0-0035028276 10.1016/S1353-8020(00)00064-X (Pubitemid 32372506)
75. Tan A., Yildirimer L., Rajadas J., De La Peña H., Pastorin G., Seifalian A., Quantum dots and carbon nanotubes in oncology: a review on emerging theranostic applications in nanomedicine. Nanomedicine 2011 6 6 1101 1114 10.2217/nnm.11.64
76. Shin S. R., Bae H., Cha J. M., Mun J. Y., Chen Y.-C., Tekin H., Shin H., Farshchi S., Dokmeci M. R., Tang S., Khademhosseini A., Carbon nanotube reinforced hybrid microgels as scaffold materials for cell encapsulation. ACS Nano 2012 6 1 362 372 10.1021/nn203711s
77. Motl R. W., Pilutti L. A., The benefits of exercise training in multiple sclerosis. Nature Reviews Neurology 2012 8 9 487 497 10.1038/nrneurol.2012.136
78. Kannan S., Dai H., Navath R. S., Balakrishnan B., Jyoti A., Janisse J., Romero R., Kannan R. M., Dendrimer-based postnatal therapy for neuroinflammation and cerebral palsy in a rabbit model. Science Translational Medicine 2012 4 130 130ra46 10.1126/scitranslmed.3003162
79. Gaillard P. J., Appeldoorn C. C. M., Rip J., Dorland R., Van Der Pol S. M. A., Kooij G., De Vries H. E., Reijerkerk A., Enhanced brain delivery of liposomal methylprednisolone improved therapeutic efficacy in a model of neuroinflammation. Journal of Controlled Release 2012 164 3 364 369 10.1016/j.jconrel.2012.06.022
80. Dai H., Navath R. S., Balakrishnan B., Guru B. R., Mishra M. K., Romero R., Kannan R. M., Kannan S., Intrinsic targeting of inflammatory cells in the brain by polyamidoamine dendrimers upon subarachnoid administration. Nanomedicine 2010 5 9 1317 1329 2-s2.0-78650070100 10.2217/nnm.10.89
81. Menjoge A. R., Kannan R. M., Tomalia D. A., Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discovery Today 2010 15 5-6 171 185 2-s2.0-77949275122 10.1016/j.drudis.2010.01. 009
82. Singh A. V., Rahman A., Sudhir Kumar N. V. G., Aditi A. S., Galluzzi M., Bovio S., Barozzi S., Montani E., Parazzoli D., Bio-inspired approaches to design smart fabrics. Materials and Design 2012 36 829 839 10.1016/j.matdes. 2011.01.061
83. Singh A. V., Ajay A.S., Aditi N., Nanomaterials: new generation therapeutics in wound healing and tissue repair. Current Nanoscience 2010 6 577 586
84. Singh A. V., Maheshwari S., Giovanni D., Naikmasur V. G., Rai A., Aditi A. S., Gade W. N., Vyas V., Gemmati D., Zeri G., Orioli E., Nanoengineering approaches to design advanced dental materials for clinical applications. Journal of Bionanoscience 2010 4 1-2 53 65 10.1166/jbns.2010.1026
85. Sant S., Tao S. L., Fisher O. Z., Xu Q., Peppas N. A., Khademhosseini A., Microfabrication technologies for oral drug delivery. Advanced Drug Delivery Reviews 2012 64 6 496 507 10.1016/j.addr.2011.11.013
86. Kohli V., Elezzabi A. Y., Prospects and developments in cell and embryo laser nanosurgery. Wiley Interdisciplinary Reviews 2009 1 1 11 25 2-s2.0-65649113157 10.1002/wnan.29
87. Ebbesen M., Jensen T. G., Nanomedicine: techniques, potentials, and ethical implications. Journal of Biomedicine and Biotechnology 2006 2006 11 2-s2.0-33845865260 10.1155/JBB/2006/51516 51516 (Pubitemid 46026579)
88. Khawaja A. M., The legacy of nanotechnology: revolution and prospects in neurosurgery. International Journal of Surgery 2011 9 8 608 614 10.1016/j.ijsu.2011.10.002
89. Freitas R. A., Nanotechnology, nanomedicine and nanosurgery. International Journal of Surgery 2005 3 4 243 246 2-s2.0-31144457810 10.1016/j.ijsu.2005.10.007 (Pubitemid 43136471)
90. Tserevelakis G. J., Psycharakis S., Resan B., Brunner F., Gavgiotaki E., Weingarten K., Filippidis G., Femtosecond laser nanosurgery of sub-cellular structures in HeLa cells by employing Third Harmonic Generation imaging modality as diagnostic tool. Journal of Biophotonics 2012 5 2 200 207 10.1002/jbio.201100055
91. Jeffries G. D. M., Edgar J. S., Yiqiong Z., Shelby J. P., Christine F., Chiu D. T., Using polarization-shaped optical vortex traps for single-cell nanosurgery. Nano Letters 2007 7 2 415 420 2-s2.0-33847729959 10.1021/nl0626784 (Pubitemid 46383607)
92. Obataya I., Nakamura C., Han S., Nakamura N., Miyake J., Nanoscale operation of a living cell using an atomic force microscope with a nanoneedle. Nano Letters 2005 5 1 27 30 2-s2.0-12844253726 10.1021/nl0485399 (Pubitemid 40168898)
93. Wang J., Gao W., Nano/microscale motors: biomedical opportunities and challenges. ACS Nano 2012 6 7 5745 5751 10.1021/nn3028997
94. Hernot S., Unnikrishnan S., Du Z., Shevchenko T., Cosyns B., Broisat A., Toczek J., Caveliers V., Muyldermans S., Lahoutte T., Klibanov A. L., Devoogdt N., Nanobody-coupled microbubbles as novel molecular tracer. Journal of Controlled Release 2012 158 2 346 353 10.1016/j.jconrel.2011.12.007
95. Farra R., Sheppard N. F. Jr., McCabe L., Neer R. M., Anderson J. M., Santini J. T. Jr., Cima M. J., Langer R., First-in-human testing of a wirelessly controlled drug delivery microchip. Science Translational Medicine 2012 4 122 122ra21 10.1126/scitranslmed.3003276
96. Qureshi W. A., Current and future applications of the capsule camera. Nature Reviews Drug Discovery 2004 3 5 447 450 2-s2.0-2442587873 (Pubitemid 38618126)
97. Swain P. C., Wireless capsule endoscopy. Gut 2003 52 supplement 4 iv48 iv50 2-s2.0-0038629106 (Pubitemid 36609705)
98. Georganopoulou D. G., Chang L., Nam J. M., Thaxton C. S., Mufson E. J., Klein W. L., Mirkin C. A., Nanoparticle-based detection in cerebral spinal fluid of a soluble pathogenic biomarker for Alzheimer's disease. Proceedings of the National Academy of Sciences of the United States of America 2005 102 7 2273 2276 2-s2.0-14044279957 10.1073/pnas.0409336102 (Pubitemid 40279365)
99. Nam J. M., Jang K. J., Groves J. T., Detection of proteins using a colorimetric bio-barcode assay. Nature Protocols 2007 2 6 1438 1444 2-s2.0-34250781676 10.1038/nprot.2007.201 (Pubitemid 46952323)
100. Warntjes J. B. M., Dahlqvist Leinhard O., West J., Lundberg P., Rapid magnetic resonance quantification on the brain: optimization for clinical usage. Magnetic Resonance in Medicine 2008 60 2 320 329 2-s2.0-49049099802 10.1002/mrm.21635
101. Haes A. J., Chang L., Klein W. L., Van Duyne R. P., Detection of a biomarker for Alzheimer's disease from synthetic and clinical samples using a nanoscale optical biosensor. Journal of the American Chemical Society 2005 127 7 2264 2271 2-s2.0-13944250934 10.1021/ja044087q (Pubitemid 40270531)
102. Kurland N. E., Drira Z., Yadavalli V. K., Measurement of nanomechanical properties of biomolecules using atomic force microscopy. Micron 2012 43 2-3 116 128 10.1016/j.micron.2011.07.017
103. Mani V., Chikkaveeraiah B. V., Patel V., Gutkind J. S., Rusling J. F., Ultrasensitive immunosensor for cancer biomarker proteins using gold nanoparticle film electrodes and multienzyme-particle amplification. ACS Nano 2009 3 3 585 594 2-s2.0-63649096688 10.1021/nn800863w
104. Neely A., Perry C., Varisli B., Singh A. K., Arbneshi T., Senapati D., Kalluri J. R., Ray P. C., Ultrasensitive and highly selective detection of alzheimer's disease biomarker using two-photon rayleigh scattering properties of gold nanoparticle. ACS Nano 2009 3 9 2834 2840 2-s2.0-70349504021 10.1021/nn900813b
105. Heta Y., Kumaki K., Hifumi H., Citterio D., Tanimoto A., Suzuki K., Gadolinium containing photochromic micelles as potential magnetic resonance imaging traceable drug carriers. Photochemistry and Photobiology 2012 88 4 876 883 10.1111/j.1751-1097.2012.01124.x
106. Richards J. M. J., Shaw C. A., Lang N. N., Williams M. C., Semple S. I. K., MacGillivray T. J., Gray C., Crawford J. H., Alam S. R., Atkinson A. P. M., Forrest E. K., Bienek C., Mills N. L., Burdess A., Dhaliwal K., Simpson A. J., Wallace W. A., Hill A. T., Roddie P. H., McKillop G., Connolly T. A., Feuerstein G. Z., Barclay G. R., Turner M. L., Newby D. E., In vivo mononuclear cell tracking using superparamagnetic particles of iron oxide feasibility and safety in humans. Circulation 2012 5 4 509 517 10.1161/CIRCIMAGING.112.972596
107. Metz S., Beer A. J., Settles M., Pelisek J., Botnar R. M., Rummeny E. J., Heider P., Characterization of carotid artery plaques with USPIOenhanced MRI: assessment of inflammation and vascularity as in vivo imaging biomarkers for plaque vulnerability. International Journal of Cardiovascular Imaging 2011 27 6 901 912 10.1007/s10554-010-9736-7
108. Bataveljić D., Stamenković S., Bačić G., Andjus P. R., Imaging cellular markers of neuroinflammation in the brain of the rat model of amyotrophic lateral sclerosis. Acta Physiologica Hungarica 2011 98 1 27 31 2-s2.0-79952578338 10.1556/APhysiol.98.2011.1.4
109. MacHtoub L., Pfeiffer R., Backovic A., Frischauf S., Wick M. C., Molecular imaging cellular SPIO uptake with nonlinear optical microscopy. Journal of Medical Imaging and Radiation Sciences 2010 41 3 159 164 2-s2.0-77957685757 10.1016/j.jmir.2010.08.001
110. Santra S., Jativa S. D., Kaittanis C., Normand G., Grimm J., Perez J. M., Gadolinium-encapsulating iron oxide nanoprobe as activatable NMR/MRI contrast agent. ACS Nano 2012 6 8 7281 7294 10.1021/nn302393e
111. Jacobs A. H., Tavitian B., Noninvasive molecular imaging of neuroinflammation. Journal of Cerebral Blood Flow and Metabolism 2012 32 7 1393 1415 10.1038/jcbfm.2012.53